'In silico' toxicology methods in drug safety assessment

While experimental animal investigation has historically been the most conventional approach conducted to assess drug safety and is currently considered the main method for determining drug toxicity, these studies are constricted by cost, time, and ethical approvals. Over the last 20 years, there ha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Đukić-Ćosić Danijela, Baralić Katarina, Jorgovanović Dragica, Živančević Katarina, Javorac Dragana, Stojilković Nikola, Radović Biljana, Marić Đurđica, Ćurčić Marijana, Buha-Đorđević Aleksandra, Bulat Zorica, Antonijević-Miljaković Evica, Antonijević Biljana
Formato: article
Lenguaje:SR
Publicado: Pharmaceutical Association of Serbia, Belgrade, Serbia 2021
Materias:
Acceso en línea:https://doaj.org/article/599af345e7b847f1b69859fde706730f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:While experimental animal investigation has historically been the most conventional approach conducted to assess drug safety and is currently considered the main method for determining drug toxicity, these studies are constricted by cost, time, and ethical approvals. Over the last 20 years, there have been significant advances in computational sciences and computer data processing, while knowledge of alternative techniques and their application has developed into a valuable skill in toxicology. Thus, the application of in silico methods in drug safety assessment is constantly increasing. They are very complex and are grounded on accumulated knowledge from toxicology, bioinformatics, biochemistry, statistics, mathematics, as well as molecular biology. This review will summarize current state-of-the-art scientific data on the use of in silico methods in toxicity testing, taking into account their shortcomings, and highlighting the strategies that should deliver consistent results, while covering the applications of in silico methods in preclinical trials and drug impurities toxicity testing.